Molecular Mechanisms of SteroidInduced Glaucoma

Young Kwon, MD, PhD
The University of Iowa (Iowa City, IA)
Year Awarded:
2004
Grant Duration:
April 1, 2004 to March 31, 2006
Disease:
Glaucoma
Award Amount:
$69,334
Grant Reference ID:
G2004018
Award Type:
Standard
Award Region:
US Midwestern

Molecular Mechanisms of SteroidInduced Glaucoma

Details

Steroid medications are widely used to treat many inflammatory conditions. However, there can be undesirable side effects of steroid use, especially when they are used long-term. One of the side effects in the eye is the development of increased eye pressure, which can lead to glaucoma and, ultimately, vision loss. Approximately one out of every three normal people is at risk of developing steroid-induced glaucoma. Using donor eyes, Dr. Kwon and his team are comparing the differences between people who develop steroid-induced glaucoma and those who do not. It is already known that steroids influence which genes are turned on and off in the body's cells, including the drainage area of the eye called the trabecular meshwork. Dr. Kwon's research will help scientists understand why the pressure in the eye is maintained at a constant level in some people, and what goes wrong in the eyes of those who react to steroids with an elevation of eye pressure. It is hoped that this information will be helpful in finding treatments that avoid steroid-induced glaucoma, allowing the safer use of steroids in patients with ocular inflammation.
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.